menu search

Phio pharma shares shine after positive ph-894 preclinical data at aacr presentation

Phio Pharmaceuticals Corp (NASDAQ: PHIO) has presented new preclinical data for PH-894, a self-deliv...

April 8, 2022, 2:19 pm

Repare therapeutics to present new clinical and preclinical data at the 2022 aacr annual meeting

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...

April 8, 2022, 1:00 pm

Jazz, werewolf sign licensing deal worth up to $1.2 billion

Shares of Werewolf Therapeutics Inc. jumped 10.8% in premarket trading on Thursday after the company announced a licensing deal with Jazz Pharmaceutic...

April 7, 2022, 8:34 am

Betterlife says betr-001 demonstrates strong anti-depressant activity in preclinical models of depression

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF), a biotech company focused on the development and commercialization of cutting-edge treatments for menta...

April 6, 2022, 1:03 pm

Zai lab to present new oncology research at 2022 aacr annual meeting

-  First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation...

April 6, 2022, 8:01 am

Vyne therapeutics shares jump on encouraging preclinical data from vyn201 program in rheumatoid arthritis

VYNE Therapeutics Inc (NASDAQ: VYNE) announced positive preclinical data from its VYN201 program in ...

March 30, 2022, 11:43 am

Angle's liquid biopsy system may aid rapid assessment of response to chemotherapy, research reveals

ANGLE PLC (AIM:AGL, OTCQX:ANPCY)'s liquid biopsy system may be able to provide a rapid assessment of how a patient is responding to chemotherapy treat...

March 29, 2022, 3:08 am

Celsion corporation to hold year-end 2021 financial results and business update conference call on thursday, march 31, 2022

LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation  (NASDAQ: CLSN), a clinical-stage development company focused on DNA-base...

March 24, 2022, 9:00 am

Sorrento's chimeric mrna covid-19 vaccine candidate shows preclinical action against omicron variants

Sorrento Therapeutics Inc (NASDAQ: SRNE) announced the publication of a preprint entitled "Chimeric mRNA based COVID-19 vaccine induces protective ...

March 21, 2022, 10:20 am

Betterlife pharma says preclinical data has confirmed bioavailability of betr-001

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) announced it had confirmed the bioavailability of its lead compound BETR-001 in the brain tissue and pla...

March 16, 2022, 4:57 pm

Gain therapeutics posts encouraging preclinical data from parkinson's, alzheimer's programs

Gain Therapeutics Inc (NASDAQ: GANX) has presented new preclinical data from its Parkinson's and Alz...

March 15, 2022, 12:20 pm

Why are altamira therapeutics shares gaining today?

Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are surging after announcing preclinical efficacy dat...

March 11, 2022, 1:52 pm

Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...

March 9, 2022, 8:21 am

Caribou biosciences to present preclinical data on cb-011, an immune-cloaked allogeneic anti-bcma car-t cell therapy, at the american association for cancer research (aacr) annual meeting

BERKELEY, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharm...

March 8, 2022, 8:19 pm

Genocea to present clinical and preclinical data at aacr annual meeting

Company to present late-breaking clinical trial update for TiTAN trial of GEN-011, Genocea's neoantigen-targeted peripheral T cell therapy for solid t...

March 8, 2022, 5:39 pm

Nuvalent to present new preclinical data on ros1-selective inhibitor nvl-520 and alk-selective inhibitor nvl-655 at aacr annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clin...

March 8, 2022, 5:38 pm

Omega therapeutics to present preclinical data for otx-2002 at the american association for cancer research annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneeri...

March 8, 2022, 5:05 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm


Search within

Pages Search Results: